FAR Issue Vol. 51/No. 178 Section II  
Issue Date: September 12, 2025
 
Total number of notices in Section II:    2

Notice /
Adopted
Section Description ID Publish
Date
View Text Proposed
2-40.008
The proposed rule is intended to reschedule Xylazine, a drug product approved by the U.S. Food and Drug Administration (FDA) as an Animal Drug Product, from Schedule I to a Schedule I with exception for Veterinary use. 29981456 9/12/2025
Vol. 51/178
View Text Proposed
33-602.112
Provisions for the notification of the death of an inmate while in the custody of the Department. 29982620 9/12/2025
Vol. 51/178